Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-008780

CEO sold 23,100 shares at an average $103.02 ($2,379,779)

  • CEO acquired 23,100 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Zovighian Bernard J · CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-09 Exercise or conversion : show line 1 in the form 10b5-1 +23,100 $72.68 $1,678,908 121,945 D
2026-11-09 Sale : show line 2 in the form 10b5-1 −9,184 $103.39 $949,489 112,761 D
2026-11-09 Sale : show line 3 in the form 10b5-1 −13,916 $102.78 $1,430,291 98,845 D
Open-market sales · 23,100 sh · avg $103.02 · $2,379,779

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-09 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) −23,100 23,100 D
Loading xslF345X06/doc4.xml…